UNLABELLED: Using data from long-term glucocorticoid users and long-term care residents, we evaluated osteoporosis prescribing patterns related to physician behavior and common practice settings. We found no significant clustering effect for common practice setting, suggesting that osteoporosis quality improvement (QI) efforts may be able to ignore this factor in designing QI interventions. INTRODUCTION: Patients' receipt of prescription therapies are significantly influenced by their physician's prescribing patterns. If physicians in the same practice setting influence one another's prescribing, evidence implementation interventions must consider targeting the practice as well as individual physicians to achieve maximal success. METHODS: We examined receipt of osteoporosis treatment (OP Rx) from two prior evidence implementation studies: long-term glucocorticoid (GC) users and nursing home (NH) residents with prior fracture or osteoporosis. Common practice setting was defined as doctors practicing at the same address or in the same nursing home. Alternating logistic regression evaluated the relationship between OP Rx, common practice setting, and individual physician treatment patterns. RESULTS: Among 6,281 GC users in 1,296 practices, the proportion receiving OP Rx in each practice was 6-100%. Among 779 NH residents in 66 nursing homes, the proportion in each NH receiving OP Rx was 0-100%. In both, there was no significant relationship between receipt of OP Rx and common practice setting after accounting for treatment pattern of individual physicians. CONCLUSION: Physicians practicing together were not more alike in prescribing osteoporosis medications than those in different practices. Osteoporosis quality improvement may be able to ignore common practice settings and maximize statistical power by targeting individual physicians.
UNLABELLED: Using data from long-term glucocorticoid users and long-term care residents, we evaluated osteoporosis prescribing patterns related to physician behavior and common practice settings. We found no significant clustering effect for common practice setting, suggesting that osteoporosis quality improvement (QI) efforts may be able to ignore this factor in designing QI interventions. INTRODUCTION:Patients' receipt of prescription therapies are significantly influenced by their physician's prescribing patterns. If physicians in the same practice setting influence one another's prescribing, evidence implementation interventions must consider targeting the practice as well as individual physicians to achieve maximal success. METHODS: We examined receipt of osteoporosis treatment (OP Rx) from two prior evidence implementation studies: long-term glucocorticoid (GC) users and nursing home (NH) residents with prior fracture or osteoporosis. Common practice setting was defined as doctors practicing at the same address or in the same nursing home. Alternating logistic regression evaluated the relationship between OP Rx, common practice setting, and individual physician treatment patterns. RESULTS: Among 6,281 GC users in 1,296 practices, the proportion receiving OP Rx in each practice was 6-100%. Among 779 NH residents in 66 nursing homes, the proportion in each NH receiving OP Rx was 0-100%. In both, there was no significant relationship between receipt of OP Rx and common practice setting after accounting for treatment pattern of individual physicians. CONCLUSION: Physicians practicing together were not more alike in prescribing osteoporosis medications than those in different practices. Osteoporosis quality improvement may be able to ignore common practice settings and maximize statistical power by targeting individual physicians.
Authors: Marion K Campbell; Sean Thomson; Craig R Ramsay; Graeme S MacLennan; Jeremy M Grimshaw Journal: Comput Biol Med Date: 2004-03 Impact factor: 4.589
Authors: Jeffrey R Curtis; Andrew O Westfall; Jeroan Allison; Angela Becker; Mary Elkins Melton; Allison Freeman; Catarina I Kiefe; Marilyn MacArthur; Theresa Ockershausen; Emily Stewart; Norm Weissman; Kenneth G Saag Journal: Arch Intern Med Date: 2007-03-26
Authors: Cathleen S Colón-Emeric; Kenneth W Lyles; Paul House; Deborah A Levine; Anna P Schenck; Jeroan Allison; Joel Gorospe; Mary Fermazin; Kristi Oliver; Jeffrey R Curtis; Norman Weissman; Aiyuan Xie; Kenneth G Saag Journal: Am J Med Date: 2007-10 Impact factor: 4.965
Authors: M Alan Brookhart; Daniel H Solomon; Philip Wang; Robert J Glynn; Jerry Avorn; Sebastian Schneeweiss Journal: J Clin Epidemiol Date: 2005-11-07 Impact factor: 6.437
Authors: Jeffrey R Curtis; Andrew O Westfall; Jeroan J Allison; Angela Becker; Linda Casebeer; Allison Freeman; Claire M Spettell; Norman W Weissman; Scott Wilke; Kenneth G Saag Journal: Arthritis Rheum Date: 2005-08
Authors: Cathleen S Colón-Emeric; Linda Casebeer; Kenneth Saag; Jeroan Allison; Deborah Levine; Theodore T Suh; Kenneth W Lyles Journal: J Am Med Dir Assoc Date: 2005 May-Jun Impact factor: 4.669
Authors: C Colón-Emeric; K W Lyles; D A Levine; P House; A Schenck; J Gorospe; M Fermazin; K Oliver; J Alison; N Weisman; A Xie; J R Curtis; K Saag Journal: Osteoporos Int Date: 2006-11-21 Impact factor: 4.507
Authors: Sarah D Berry; Andrew R Zullo; Yoojin Lee; Vincent Mor; Kevin W McConeghy; Geetanjoli Banerjee; Ralph B D'Agostino; Lori Daiello; David Dosa; Douglas P Kiel Journal: J Gerontol A Biol Sci Med Sci Date: 2018-05-09 Impact factor: 6.053
Authors: Courtney C Kennedy; George Ioannidis; Lehana Thabane; Jonathan D Adachi; Denis O'Donnell; Lora M Giangregorio; Laura E Pickard; Alexandra Papaioannou Journal: Can J Aging Date: 2015-04-08
Authors: Gustavo Duque; Stephen R Lord; Jenson Mak; Kirtan Ganda; Jacqueline J T Close; Peter Ebeling; Alexandra Papaioannou; Charles A Inderjeeth Journal: J Am Med Dir Assoc Date: 2016-06-24 Impact factor: 4.669